Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Diabetes Reports
Erschienen in: Current Diabetes Reports 9/2021

01.09.2021 | Microvascular Complications—Retinopathy (R Channa, Section Editor)

The Role of Ultra-Widefield Fundus Imaging and Fluorescein Angiography in Diagnosis and Treatment of Diabetic Retinopathy

verfasst von: Sophie Cai, T. Y. Alvin Liu

Erschienen in: Current Diabetes Reports | Ausgabe 9/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Early detection and treatment are important for preventing vision loss from diabetic retinopathy. Historically, the gold standard for grading diabetic retinopathy has been based on 7-field 30-degree color fundus photographs that capture roughly the central third of the retina. Our aim was to review recent literature on the role of ultra-widefield (allowing capture of up to 82% of the retina in one frame) fundus imaging in screening, prognostication, and treatment of diabetic retinopathy.

Recent Findings

Ultra-widefield fundus imaging can capture peripheral retinal lesions outside the traditional 7-field photographs that may correlate with increased risk of diabetic retinopathy progression. The speed and ability to image through undilated pupils make ultra-widefield imaging attractive for tele-ophthalmology screening. Ultra-widefield fluorescein angiography may help guide targeted laser treatment in eyes with proliferative diabetic retinopathy.

Summary

Ultra-widefield imaging has potential to help shape new diabetic retinopathy screening, staging, and treatment protocols.
Literatur
1.
Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC, et al. Guidelines on diabetic eye care: the International Council of Ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology. 2018;125:1608–22.CrossRef
2.
Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124–36.CrossRef
3.
Feman SS. The natural history of the first clinically visible features of diabetic retinopathy. Trans Am Ophthalmol Soc. 1994;92:745–73.PubMedPubMedCentral
4.
Russell JF, Shi Y, Scott NL, Gregori G, Rosenfeld PJ. Longitudinal angiographic evidence that intraretinal microvascular abnormalities can evolve into neovascularization. Ophthalmol Retina. 2020;4:1146–50.CrossRef
5.
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–64.CrossRef
6.
Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 1981;21:1–226.
7.
Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:786–806.
8.
Silva PS, Cavallerano JD, Haddad NM, Kwak H, Dyer KH, Omar AF, et al. Peripheral lesions identified on ultrawide field imaging predict increased risk of diabetic retinopathy progression over 4 years. Ophthalmology. 2015;122:949–56.CrossRef
9.
Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology. 1981;88:583–600.
10.
Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:766–85.
11.
Choudhry N, Duker JS, Freund KB, Kiss S, Querques G, Rosen R, et al. Classification and guidelines for widefield imaging: recommendations from the International Widefield Imaging Study Group. Ophthalmol Retina. 2019;3:843–9.CrossRef
12.
Patel SN, Shi A, Wibbelsman TD, Klufas MA. Ultra-widefield retinal imaging: an update on recent advances. Ther Adv Ophthalmol. 2020;12:2515841419899495.PubMedPubMedCentral
13.
Kernt M, Hadi I, Pinter F, Seidensticker F, Hirneiss C, Haritoglou C, et al. Assessment of diabetic retinopathy using nonmydriatic ultra-widefield scanning laser ophthalmoscopy (Optomap) compared with ETDRS 7-field stereo photography. Diabetes Care. 2012;35:2459–63.CrossRef
14.
Hirano T, Imai A, Kasamatsu H, Kakihara S, Toriyama Y, Murata T. Assessment of diabetic retinopathy using two ultra-wide-field fundus imaging systems, the Clarus and Optos systems. BMC Ophthalmol. 2018;18:332.
15.
Verma A, Alagorie AR, Ramasamy K, van Hemert J, Yadav NK, Pappuru RR, et al. Distribution of peripheral lesions identified by mydriatic ultra-wide field fundus imaging in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2020;258:725–33.CrossRef
16.
Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:823–33.
17.••
Aiello LP, Odia I, Glassman AR, Melia M, Jampol LM, Bressler NM, et al. Comparison of early treatment diabetic retinopathy study standard 7-field imaging with ultrawide-field imaging for determining severity of diabetic retinopathy. JAMA Ophthalmol. 2019;137:65–73 This is a prospective observational study intended to evaluate the role of ultra-widefield fundus imaging compared to ETDRS 7-field 30-degree color fundus photographs for diabetic retinopathy staging and prognostication.CrossRef
18.
Afshar AR, Oldenburg CE, Stewart JM. A novel hybrid fixed and mobile ultra-widefield imaging program for diabetic teleretinopathy screening. Ophthalmol Retina. 2019;3:576–9.CrossRef
19.
Hussain N, Edraki M, Tahhan R, Sanalkumar N, Kenz S, Akasha NK, et al. Telemedicine for diabetic retinopathy screening using an ultra-widefield fundus camera. Clin Ophthalmol. 2017;11:1477–82.CrossRef
20.••
Lois N, Cook JA, Wang A, Aldington S, Mistry H, Maredza M, et al. Evaluation of a new model of care for people with complications of diabetic retinopathy: the EMERALD study. Ophthalmology. 2021;128:561–73 This is a prospective multicenter study showing that trained nonmedical graders can screen for proliferative diabetic retinopathy from ultra-widefield fundus images with high sensitivity compared to ophthalmologists.CrossRef
21.
Bhaskaranand M, Ramachandra C, Bhat S, Cuadros J, Nittala MG, Sadda SR, et al. The value of automated diabetic retinopathy screening with the EyeArt system: a study of more than 100,000 consecutive encounters from people with diabetes. Diabetes Technol Ther. 2019;21:635–43.CrossRef
22.
Wang K, Jayadev C, Nittala MG, Velaga SB, Ramachandra CA, Bhaskaranand M, et al. Automated detection of diabetic retinopathy lesions on ultrawidefield pseudocolour images. Acta Ophthalmol. 2018;96:e168–e73.CrossRef
23.••
Tang F, Luenam P, Ran AR, Quadeer AA, Raman R, Sen P, et al. Detection of diabetic retinopathy from ultra-widefield scanning laser ophthalmoscope images: a multicenter deep learning analysis. Ophthalmol Retina. 2021 Feb 1;S2468-6530(21):00035-X. This is a multicenter study showing that a deep learning model can achieve high sensitivity and specificity in classifying diabetic retinopathy from ultra-widefield fundus images.
24.
Ehlers JP, Jiang AC, Boss JD, Hu M, Figueiredo N, Babiuch A, et al. Quantitative ultra-widefield angiography and diabetic retinopathy severity: an assessment of panretinal leakage index, ischemic index and microaneurysm count. Ophthalmology. 2019;126:1527–32.CrossRef
25.
Antaki F, Coussa RG, Mikhail M, Archambault C, Lederer DE. The prognostic value of peripheral retinal nonperfusion in diabetic retinopathy using ultra-widefield fluorescein angiography. Graefes Arch Clin Exp Ophthalmol. 2020;258:2681–90.CrossRef
26.••
Nicholson L, Ramu J, Chan EW, Bainbridge JW, Hykin PG, Talks SJ, et al. Retinal nonperfusion characteristics on ultra-widefield angiography in eyes with severe nonproliferative diabetic retinopathy and proliferative diabetic retinopathy. JAMA Ophthalmol. 2019;137:626–31 This is a post hoc analysis of randomized controlled trial data that identified a threshold amount of nonperfusion on ultra-widefield fluorescein angiography that can help distinguish between eyes with nonproliferative and proliferative diabetic retinopathy.CrossRef
27.
Yu G, Aaberg MT, Patel TP, Iyengar RS, Powell C, Tran A, et al. Quantification of retinal nonperfusion and neovascularization with ultrawidefield fluorescein angiography in patients with diabetes and associated characteristics of advanced disease. JAMA Ophthalmol. 2020;138:680–8.CrossRef
28.
Jiang A, Srivastava S, Figueiredo N, Babiuch A, Hu M, Reese J, et al. Repeatability of automated leakage quantification and microaneurysm identification utilising an analysis platform for ultra-widefield fluorescein angiography. Br J Ophthalmol. 2020;104:500–3.CrossRef
29.
Babiuch AS, Wykoff CC, Srivastava SK, Talcott K, Zhou B, Hach J, et al. Retinal leakage index dynamics on ultra-widefield fluorescein angiography in eyes treated with intravitreal aflibercept for proliferative diabetic retinopathy in the recovery study. Retina. 2020;40:2175–83.CrossRef
30.
Gross JG, Glassman AR, Liu D, Sun JK, Antoszyk AN, Baker CW, et al. Five-year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA Ophthalmol. 2018;136:1138–48.CrossRef
31.
Writing Committee for the Diabetic Retinopathy Clinical Research N, Gross JG, Glassman AR, Jampol LM, Inusah S, Aiello LP, et al. Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA. 2015;314:2137–46.CrossRef
32.
Hutton DW, Stein JD, Glassman AR, Bressler NM, Jampol LM, Sun JK, et al. Five-year cost-effectiveness of intravitreous ranibizumab therapy vs panretinal photocoagulation for treating proliferative diabetic retinopathy: a secondary analysis of a randomized clinical trial. JAMA Ophthalmol. 2019;137:1424–1432.
33.
Obeid A, Su D, Patel SN, Uhr JH, Borkar D, Gao X, et al. Outcomes of eyes lost to follow-up with proliferative diabetic retinopathy that received panretinal photocoagulation versus intravitreal anti-vascular endothelial growth factor. Ophthalmology. 2019;126:407–13.CrossRef
34.
Pahor D. Visual field loss after argon laser panretinal photocoagulation in diabetic retinopathy: full- versus mild-scatter coagulation. Int Ophthalmol. 1998;22:313–9.CrossRef
35.
Muqit MM, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ, et al. Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy. Acta Ophthalmol. 2013;91:251–8.CrossRef
36.••
Nikkhah H, Ghazi H, Razzaghi MR, Karimi S, Ramezani A, Soheilian M. Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial. Int Ophthalmol. 2018;38:313–21 This is a randomized controlled trial suggesting that targeted panretinal photocoagulation guided by areas of nonperfusion on ultra-widefield fluorescein angiography may be a viable alternative to conventional panretinal photocoagulation for treatment of proliferative diabetic retinopathy, with fewer laser spots and potentially less loss of visual field.CrossRef
37.
Liu J, Gibson E, Ramchal S, Shankar V, Piggott K, Sychev Y, et al. Diabetic retinopathy screening with automated retinal image analysis in a primary care setting improves adherence to ophthalmic care. Ophthalmol Retina. 2021;5:71–7.CrossRef
38.
Martinez JA, Parikh PD, Wong RW, Harper CA, Dooner JW, Levitan M, et al. Telemedicine for diabetic retinopathy screening in an urban, insured population using fundus cameras in a primary care office setting. Ophthalmic Surg Lasers Imaging Retina. 2019;50:e274–e7.CrossRef
Metadaten
Titel
The Role of Ultra-Widefield Fundus Imaging and Fluorescein Angiography in Diagnosis and Treatment of Diabetic Retinopathy
verfasst von
Sophie Cai
T. Y. Alvin Liu
Publikationsdatum
01.09.2021
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 9/2021
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-021-01398-0

Weitere Artikel der Ausgabe 9/2021

Current Diabetes Reports 9/2021 Zur Ausgabe

Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (B Conway and H Keenan, Section Editors)

Efficacy of Ketogenic Diets on Type 2 Diabetes: a Systematic Review

Microvascular Complications—Retinopathy (R Channa, Section Editor)

Laser Therapy in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema

Microvascular Complications—Retinopathy (R Channa, Section Editor)

Management of Complications and Vision Loss from Proliferative Diabetic Retinopathy

Macrovascular Complications in Diabetes (VS Aroda and L-S Chang, Section Editors)

Cardiovascular Risk Management in Type 1 Diabetes

Microvascular Complications—Neuropathy (R Pop-Busui, Section Editor)

Molecular Aspects in the Potential of Vitamins and Supplements for Treating Diabetic Neuropathy

Microvascular Complications—Retinopathy (R Channa, Section Editor)

Toward a New Staging System for Diabetic Retinopathy Using Wide Field Swept-Source Optical Coherence Tomography Angiography

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise